M&A Deal Summary

The Lubrizol Acquires Vesta

On August 1, 2014, The Lubrizol acquired medical products company Vesta from RoundTable Healthcare Management

Acquisition Highlights
  • This is The Lubrizol’s 1st transaction in the Medical Products sector.
  • This is The Lubrizol’s 5th transaction in the United States.
  • This is The Lubrizol’s 1st transaction in Wisconsin.

M&A Deal Summary
Date 2014-08-01
Target Vesta
Sector Medical Products
Buyer(s) The Lubrizol
Sellers(s) RoundTable Healthcare Management
Deal Type Add-on Acquisition
Advisor(s) William Blair (Financial)

Target

Vesta

Franklin, Wisconsin, United States
Vesta, Inc. is a manufacturer and supplier of disposable silicone medical products and precision thermoplastic extrusion tubing. Major products include catheters, wound and body drains, surgical tubing, instrument seals and valves and other surgical device components.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

The Lubrizol

Wickliffe, Ohio, United States
Category Company
Founded 1928
Sector Chemicals
Employees7,000
Revenue 5.4B USD (2010)
DESCRIPTION

The Lubrizol Corporation is a specialty chemical company that produces and supplies technologies to customers in the global transportation, industrial and consumer markets. These technologies include lubricant additives for engine oils, other transportation-related fluids and industrial lubricants, as well as fuel additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for personal care products and pharmaceuticals; specialty materials, including plastics technology and performance coatings in the form of specialty resins and additives.

DEAL STATS #
Overall 8 of 15
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 7 of 14
State (Wisconsin) 1 of 1
Country (United States) 5 of 7
Year (2014) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-06-20 Lipotec SA

Barcelona, Spain

Lipotec SA is a leader in the development, manufacturing and sale of personal care ingredients based on three core technologies: peptide-based active cosmetic ingredients, delivery systems and biotechnology products.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-31 Warwick International

Flintshire, United Kingdom

Warwick consists of two separate businesses, a speciality chemical manufacturer and a broad network of niche chemical distributors based across Europe and Asia. The chemical manufacturing business is the global market leader in the production of bleach activators used in the laundry detergents market. The distribution business supplies a broad range of products used in markets including, construction, industrials, polymer, refinery, refracting and personal care.

Buy -

Seller(S) 1

SELLER

RoundTable Healthcare Management

Lake Forest, Illinois, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2001
PE ASSETS 2.9B USD
Size Large
Type Sector Focused
DESCRIPTION

RoundTable Healthcare Partners is a specialist private equity firm that targets equity and junior capital investments in the healthcare industry. Specific areas of interest include medical devices, medical products and disposables, specialty pharmaceuticals, medication delivery systems, specialty distribution, and outsourced healthcare services. RoundTable typically makes equity investments of approximately $5 to $50 million in platform companies with revenues ranging from $25 to $300 million. RoundTable will not invest in service-oriented provider segments (such as managed care companies, hospitals or nursing homes), internet or biotechnology companies, or start-up/venture situations. RoundTable was formed in 2001 and is based in Lake Forest, Illinois.

DEAL STATS #
Overall 9 of 22
Sector (Medical Products) 6 of 13
Type (Add-on Acquisition) 8 of 14
State (Wisconsin) 1 of 2
Country (United States) 8 of 21
Year (2014) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-17 Aqua Pharmaceuticals

West Chester, Pennsylvania, United States

Aqua Pharmaceuticals LLC is a specialty dermatology pharmaceutical company focused on acquiring, developing and marketing under promoted, branded, pharmaceutical products. Utilizing its direct salesforce, Aqua promotes seven products throughout the United States including Monodox® (doxycycline monohydrate) capsules, an antibiotic used to treat acne; Cordran® lotion and cream, a topical corticosteroid used for the relief of inflammatory dermatoses; and Fluoroplex® (fluorouracil) cream, indicated for the treatment of actinic keratoses.

Sell $328M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-03-10 Lineage Therapeutics

Horsham, Pennsylvania, United States

Lineage Therapeutics, Inc. is a pharmaceutical company focused on offering generic products in the United States.

Sell -
Mergr

Product

Company

Legal